Precise Biometrics and ORGA Sign Cooperative Agreement to Bring Precise Match-on-Card to the Health & ID Markets
August 15, 2002 03:57 ET
|
Precise Biometrics AB
LUND, Sweden, Aug. 15, 2002 (PRIMEZONE) -- Precise Biometrics AB (publ), developer and provider of world leading and userfriendly biometric security solutions based on fingerprints, and ORGA...
Actelion Reports Positive RAPIDS-1 Results; Actelion Reports Highly Significant Study Results With Tracleer in Digital Ulcers
August 15, 2002 01:53 ET
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, Aug. 15, 2002 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) announced today preliminary results from RAPIDS-1, evaluating the efficacy and safety of Tracleer(TM) in the...
American Cancer Society Accelerates Efforts Using Convio for Premier Breast Cancer Event Series, `Making Strides Against Breast Cancer'
August 14, 2002 13:52 ET
|
Convio
AUSTIN, Texas, Aug. 14, 2002 (PRIMEZONE) -- The American Cancer Society -- the nation's leading voluntary health organization -- is picking up the pace in the fight against breast cancer by...
Wilhelm Sonesson AB (publ.) Interim Report, January 1 - June 30, 2002
August 14, 2002 09:26 ET
|
Wilhelm Sonesson
MALMO, Sweden, Aug. 14, 2002 (PRIMEZONE) -- Wilhelm Sonesson AB:
- Streamlining of Consumer Healthcare completed
- Acquisition of Bioglan
- Successful launch of Jabu'she
- Net sales of...
Pyrosequencing Licenses DNA Technology from Harvard; Agreement Expands Intellectual Property Surrounding Cleavable Fluorescent Nucleotides
August 14, 2002 08:55 ET
|
Pyrosequencing
UPPSALA, Sweden, August 14, 2002 (PRIMEZONE) -- Pyrosequencing AB (SSE:PYROA) announced today the signing of an exclusive license agreement with Harvard that provides broad access to nucleic acid...
Hauser Reports Fiscal 2003 First Quarter Financial Results
August 14, 2002 07:30 ET
|
Hauser, Inc.
LONG BEACH, Calif. and LONGMONT, Colo., Aug. 14, 2002 (PRIMEZONE) -- Hauser, Inc. (OTCBB:HAUS) today reported financial results for its fiscal 2003 first quarter ended June 30, 2002.
For the fiscal...
Vitrolife has Divested Its Sales Rights to Ophthalin and Fermathron Including its Manufacturing Plant in Scotland
August 13, 2002 05:45 ET
|
Vitrolife
STOCKHOLM, Sweden, Aug. 13, 2002 (PRIMEZONE) -- In conjunction with the restructuring of Vitrolife's Biosupportive Systems business area, the Company has divested the sales rights of its...
Extraordinary General Meeting in Pharmexa A/S
August 05, 2002 07:09 ET
|
Pharmexa A/S
HOERSHOLM, Denmark, Aug. 5, 2002 (PRIMEZONE) -- Pursuant to article 8 of the Articles of Association the shareholders of Pharmexa A/S are hereby convened to the Extraordinary General Meeting on
...
New Warrant Program in Pharmexa
August 01, 2002 07:15 ET
|
Pharmexa A/S
HOERSHOLM, Denmark, August 1, 2002 (PRIMEZONE) -- The board of directors in Pharmexa has approved a new warrant program to the employees and management group of the company. The warrant program...
Trigen Completes Management Team
August 01, 2002 04:25 ET
|
Trigen
LONDON, August 1, 2002 (PRIMEZONE) -- Trigen Ltd. today announced the appointment of Dr. Suresh Chahwala as VP Drug Discovery and Dr. Sophie Combe as VP Clinical Development. Both appointments bring...